Mar 20th 2013 - Edison Investment Research today published a report on Ion Beam Applications entitled "One Ring To Rule Them All". In summary, the report says:
The investment case rests on the Proteus One proton beam machine. These electromagnetic rings are faster to build and more affordable at around €30m per facility (of which €20m is the machine) vs up to €120m for a five room Proteus PLUS facility. Proteus One is gaining EU sales and FDA approval is likely in 2014; US prostates remain a big target market. By expanding the global market, the One could enable10% of cancer patients to benefit from superior proton therapy as against 1% now. IBA is still restructuring and reducing costs. Management’s end-2014 goals are for revenue growth of 5-10% and an operating margin of 10%. This requires further restructuring plus sale of non-core operations.
Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority (www.fsa.gov.uk/register/firmBasicDetails.do?sid=181584). more »